NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/19/2022
Back to search
Official data from USPTO
GENERATION BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GENERATION BIOTECH
ST13
US500000087794023Class
1, 42
Filing
87794023
Registration
6791849
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
07/19/2022
Trademark type
Word
Nice classes
1, 42
Filing date
02/12/2018
Registration date
07/19/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/19/2022
Last transaction
07/19/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/30/2012
First use in commerce
05/31/2013
Drawing code
4
Owner type
16
Owner location
Lawrenceville, NJ
Examiner
BROOKSHIRE,DAVID AARON
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Generation Biotech, LLC
Representatives
EAMON J. WALL MEAGHER EMANUEL LAKS GOLDBERG & LIAO, LLP
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and medical research use in connection with amplificationanalysis or labeling of nucleic acid; Reagent kits for scientific and medical research comprised of reagents and mixing tubes and pipettes for research in the field of genetic variantsgene expression regulation and the medical research in the treatment of genetic diseases based on the analysis of such specific genetic sequences or gene expression profiles
Class 42
Scientific laboratory services in the field of gene-specific nucleic acid extraction and transfer for amplificationquantificationsequencinganalysis and related consulting; Scientific and medical research of genetic variantsgene expression regulation and the medical research concerning the diagnosis or treatment of genetic diseases based on the analysis of such specific gene sequences or gene expression profiles
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/19/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2022
PUBO
PUBLISHED FOR OPPOSITION
05/03/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/13/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/30/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
08/27/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/20/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/19/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/09/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/05/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/05/2018
GNSL
LETTER OF SUSPENSION E-MAILED
12/05/2018
CNSL
SUSPENSION LETTER WRITTEN
12/05/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
12/05/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/05/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
12/05/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/05/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/03/2018
GNSL
LETTER OF SUSPENSION E-MAILED
12/03/2018
CNSL
SUSPENSION LETTER WRITTEN
12/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/30/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/05/2018
GNRT
NON-FINAL ACTION E-MAILED
06/05/2018
CNRT
NON-FINAL ACTION WRITTEN
06/05/2018
DOCK
ASSIGNED TO EXAMINER
05/28/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/20/2018
NWAP
NEW APPLICATION ENTERED
02/15/2018
Continuous trademark protection
Get notified about every new filing that threatens GENERATION BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.